Erectile dysfunction (ED) is a common medical condition that affects the sexual life of
millions of men worldwide. Many drugs are now available for treating ED; oral
pharmacotherapy represents the first‐line option for most patients with ED. Sildenafil, an
inhibitor of the enzyme phosphodiesterase type 5, is currently the most widely prescribed
oral agent and has a very satisfactory efficacy‐safety profile in all patient categories.
Apomorphine SL is a dopamine D1‐and D2‐receptor agonist which has recently been …

Pharmacological treatment of erectile dysfunction includes all therapeutic modalities based
on the use of erectogenic drugs, regardless of the route of administration. Intracavernous
vasoactive injection therapy is the most commonly used treatment for erectile dysfunction.
Most patients respond to intracavernous injection of either single or multiple vasoactive
drugs. Major adverse effects related to this treatment include priapism, corporeal pain and
the formation of nodules or plaques in the corpora cavernosa. Oral administration of drugs …